Questions? +1 (202) 540-8337 Login
Trusted News Since 1995
A service for global professionals · Wednesday, February 21, 2018 · 433,374,821 Articles · 3+ Million Readers

C-Level: China Medicine Names Finance Chief

November 24, 2010 (FinancialWire) ( — China Medicine Corp. (OTCBB: CHME) has appointed Henry Chi Fung Ho as its chief financial officer, effective November 16. Fred Cheung resigned from his position as CFO of China Medicine, effective November 16.

Ho has served as the company's VP of finance and accounting since October 1. Prior to joining China Medicine, Ho worked at Ernst & Young China from September 2005 to September 2010, Ernst & Young's Chicago office from June 2002 to August 2005, and Arthur Andersen LLP from July 1998 to May 2002.

China-based China Medicine engages in the production and distribution of prescription and over the counter drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China.


Equity research on any public company is available through the Shareholders Research Alliance (go to for more information).  Real-time, streaming research for companies and funds mentioned in FinancialWire(tm) news is available via the Investrend Research Syndicate (at  Current valuation analysis research for companies and funds mentioned in FinancialWire(tm) news is available via the Investrend Research Syndicate (at

FinancialWire(tm) is committed to serving the financial community through true journalism and providing relevant resources to investors. Standards-based, independent equity research on numerous public other companies is available through the Investrend Research Syndicate ( written by FIRST Research Consortium ( member-providers. Free annual reports and company filings for companies mentioned in the news are available through the Investrend Information Syndicate (at FinancialWire(tm), in cooperation with the Investrend Broadcast Syndicate, also provides complete, daily conference call and webcast schedules as a service to shareholders and investors via the FirstAlert(tm) Network’s “FirstAlert(tm) Daily” (at

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation from subject entities, companies, equities, or representatives thereof, for its news, opinions or distributions. Further disclosure is posted at the FinancialWire(tm) website (at and Additional resources for investors are also accessible via the FinancialWire(tm) website (at Contact FinancialWire(tm) directly via

Copyright © MMX, FinancialWire(tm); All rights reserved.

[hlmsmlh] [clvloy] [ntrntnlcmpnsbsnss] [chnchn] [biomedphrm] [btnwswntb]

Powered by EIN Presswire